Morepen Lab drops after Q1 PAT slides 70% YoY to Rs 11 cr

Image
Last Updated : Aug 06 2025 | 3:32 PM IST

Morepen Laboratories declined 4.33% to Rs 54.11 after the company's consolidated net profit tumbled 70.3% to Rs 10.74 crore on 6.59% fall in revenue from operations to Rs 425.23 crore in Q1 FY26 over Q1 FY25.

Profit before tax (PBT) fell 67.79% YoY to Rs 15.51 crore in Q1 June 2025.

Total expenses rose 0.89% to Rs 414.13 crore in Q1 FY26 compared with Rs 410.47 crore in Q1 FY25. Cost of material consumed stood at Rs 237.70 crore (up 1.14% YoY), employee benefit expenses was at Rs 55.23 crore (up 15.18% YoY), finance cost stood at Rs 4.03 crore (up 250.43% YoY), selling and distribution expenses stood at Rs 30.39 core (up 2.74% YoY) during the period under review.

Morepen Laboratories is a vertically integrated, innovation-led pharmaceutical and healthcare company delivering highquality APIs, branded generics, medical devices, and consumer wellness products to over 80 countries worldwide.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 06 2025 | 3:15 PM IST

Next Story